H.R. 5333: Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018

CBO Score

$138 million

Documentation

Date of Report

Wed June 6th, 2018

CBO Report Details

Legislation Details

115th Congress

To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.

Sponsor: Rep. Robert Latta — R — OH

To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.

View the full vote history of this bill on GovTrack.us.

As a registered user, you receive personalized updates to your inbox or dashboard when elected officials vote to spend more of your money. Choose to receive updates daily, weekly, monthly, or as they happen.

JOIN US!

Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.

Lost your Password?

Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.

×
+ + HIGH LOW +
+ + HIGH LOW +